These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2149050

  • 1. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P, Brossard G, Marit G, Pellegrin JL, Texier-Maugein J, Reiffers J.
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F, Del Favero A, Bucaneve G, Aversa F, Fiorio M.
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children.
    Schaison G, Baruchel A, Arlet G.
    Br J Haematol; 1990 Dec; 76 Suppl 2():24-6. PubMed ID: 2149047
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
    Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2246-52. PubMed ID: 1839490
    [Abstract] [Full Text] [Related]

  • 11. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C, Glasmacher A, Arns A, Mühling A, Orlopp K, Marklein G, Von Lilienfeld-Toal M.
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    Micozzi A, Venditti M, Amadori S, Pulsoni A, Tirindelli C, Martino P.
    Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
    [Abstract] [Full Text] [Related]

  • 16. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
    Chow AW, Jewesson PJ, Kureishi A, Phillips GL.
    Eur J Haematol Suppl; 1993 Dec; 54():18-24. PubMed ID: 8365461
    [Abstract] [Full Text] [Related]

  • 17. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
    Koeppler H, Pflueger KH, Seitz R, Havemann K.
    Infection; 1989 Dec; 17(3):142-5. PubMed ID: 2661438
    [Abstract] [Full Text] [Related]

  • 18. The role of gram-positive therapy in the neutropenic patient.
    Menichetti F, Del Favero A.
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
    [Abstract] [Full Text] [Related]

  • 19. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP, Bru JP, Michallet M, Corron B, Fauconnier J.
    Presse Med; 1988 Oct 26; 17(37):1964-7. PubMed ID: 2973597
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.